David Poulsen, Ph.D.

Principal Scientific Advisor

David Poulsen, Ph.D., serves as NeuroTrauma’s Principal Scientific Advisor. David is a pioneer in the field of stroke and traumatic brain injury (TBI) and in research to develop neuroprotective and neurorestorative agents. He is a tenured professor in the Department of Neurosurgery at the University at Buffalo SUNY School of Medicine and Biomedical Sciences. Prior to joining NeuroTrauma, he held numerous academic and research positions and served as Chief Science Officer for Sinapis Pharma, a stroke and traumatic brain injury-focused company. Throughout his career, David has authored five patents and has secured $7.3 million in grants from the National Institute of Health, Department of Defense, and other institutions to fund his stroke and TBI research. He has authored 68 peer-reviewed manuscripts and abstract/posters and is a sought-after speaker, having made local, state, national and international presentations dealing with neuroprotection and neurorestoration in stroke and traumatic brain injury. David received a B.S. in Microbiology from Brigham Young University and a Ph.D. from the University of Delaware in Molecular Biology and Virology.